Darko Pucar

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence
    Darko Pucar
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 69:62-9. 2007
  2. ncbi The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis
    Amita Shukla Dave
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    BJU Int 99:786-93. 2007
  3. ncbi Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging
    Oguz Akin
    Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Radiology 239:784-92. 2006
  4. ncbi Predicting post-external beam radiation therapy PSA relapse of prostate cancer using pretreatment MRI
    Michael H Fuchsjäger
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 78:743-50. 2010
  5. ncbi Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience
    Darko Pucar
    Department of Radiology, Medical Physics, Epidemiology and Biostatistics, Urology, Pathology, and Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Radiology 236:545-53. 2005
  6. ncbi Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer
    Michael Mullerad
    Departments of Urology and Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Urol 174:2158-63. 2005
  7. ncbi Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapse
    Darko Pucar
    Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Clin Prostate Cancer 3:174-81. 2004
  8. ncbi The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer
    Michael Fuchsjager
    Department of Radiology, Medical University of Vienna, Vienna, Austria, and Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Clin Adv Hematol Oncol 7:193-202. 2009
  9. ncbi The role of imaging in the detection of prostate cancer local recurrence after radiation therapy and surgery
    Darko Pucar
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Curr Opin Urol 18:87-97. 2008
  10. ncbi Advances in imaging in the postoperative patient with a rising prostate-specific antigen level
    Hedvig Hricak
    Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Semin Oncol 30:616-34. 2003

Detail Information

Publications10

  1. ncbi Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence
    Darko Pucar
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 69:62-9. 2007
    ....
  2. ncbi The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis
    Amita Shukla Dave
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    BJU Int 99:786-93. 2007
    ..To design new models that combine clinical variables and biopsy data with magnetic resonance imaging (MRI) and MR spectroscopic imaging (MRSI) data, and assess their value in predicting the probability of insignificant prostate cancer...
  3. ncbi Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging
    Oguz Akin
    Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Radiology 239:784-92. 2006
    ....
  4. ncbi Predicting post-external beam radiation therapy PSA relapse of prostate cancer using pretreatment MRI
    Michael H Fuchsjäger
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 78:743-50. 2010
    ..To investigate whether pretreatment endorectal magnetic resonance imaging (MRI) findings can predict biochemical relapse in patients with clinically localized prostate cancer treated with external beam radiation therapy (EBRT)...
  5. ncbi Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience
    Darko Pucar
    Department of Radiology, Medical Physics, Epidemiology and Biostatistics, Urology, Pathology, and Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Radiology 236:545-53. 2005
    ..CONCLUSION: In summary, MR imaging and MR spectroscopy may be more sensitive than sextant biopsy and digital rectal examination for sextant localization of cancer recurrence after external-beam radiation therapy...
  6. ncbi Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer
    Michael Mullerad
    Departments of Urology and Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Urol 174:2158-63. 2005
    ..0001). CONCLUSIONS: For prostate cancer localization erMRI contributes significant incremental value to DRE or TRUS biopsy findings (each p <0.0001)...
  7. ncbi Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapse
    Darko Pucar
    Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Clin Prostate Cancer 3:174-81. 2004
    ..Although MRSI did not provide added prognostic value to MRI in this small number of patients, MRSI might increase the confidence of the clinician in assessing risk on MRI by contributing supporting metabolic data...
  8. ncbi The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer
    Michael Fuchsjager
    Department of Radiology, Medical University of Vienna, Vienna, Austria, and Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Clin Adv Hematol Oncol 7:193-202. 2009
    ..This review will provide a brief overview of MRI techniques relevant to prostate cancer, including MR spectroscopic imaging, and discuss the ways that they can aid in diagnosis, treatment selection, and post-treatment follow-up...
  9. ncbi The role of imaging in the detection of prostate cancer local recurrence after radiation therapy and surgery
    Darko Pucar
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Curr Opin Urol 18:87-97. 2008
    ..The aim of this article is to review novel MRI and nuclear medicine methods for detecting and planning salvage treatment for prostate cancer local recurrence after radical prostatectomy or radiation therapy...
  10. ncbi Advances in imaging in the postoperative patient with a rising prostate-specific antigen level
    Hedvig Hricak
    Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Semin Oncol 30:616-34. 2003
    ..Another modality offering information about anatomy and metabolism of the local disease is PET/CT. The value of PET/CT at present is controversial, but new studies exploring the role of PET/CT in aggressive prostate cancer are promising...